DSP Healthcare Fund
- NAV as on 9 Nov 2026
- ₹46.89+2.34%1 day
- Return since launch
- 21.1%
- 52-week range
- ₹35.84 — ₹46.15
- AUM
- ₹3,750 Cr
DSP Healthcare Fund is a Sectoral-Pharma equity fund from DSP Mutual Fund with ₹3,750 Cr under management, launched in 2018. Over three years it has returned 15.6% a year, against 21.2% for its category. The expense ratio is 2.05% and the SEBI riskometer reading is Very High.
Performance
DSP Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +15.0% against +16.7% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 29.8% | +9.0 pts | 20.8% | 29.1% |
| 2Y | 16.9% | −2.2 pts | 19.1% | 17.6% |
| 3Y | 15.6% | −5.7 pts | 21.2% | 16.0% |
| 5Y | 19.0% | +3.5 pts | 15.4% | 18.5% |
| 7Y | 19.3% | +0.4 pts | 18.9% | 18.0% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 6.7% | −1.8 pts | 8.4% | 8.5% |
| 3M | 4.1% | +0.4 pts | 3.7% | 3.7% |
| 6M | 17.4% | +3.4 pts | 14.0% | 13.6% |
| 1Y | 16.9% | −3.9 pts | 20.8% | 19.4% |
| 2Y | 7.0% | −3.9 pts | 10.8% | 9.5% |
| 3Y | 20.2% | −1.0 pts | 21.2% | 20.0% |
| 5Y | 15.6% | +0.2 pts | 15.4% | 14.6% |
| 7Y | 23.7% | +1.3 pts | 22.4% | 21.2% |
Since launch (12 Nov 2018): 21.1%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -5.8% | −3.8 pts | -2.0% |
| 2024 | 40.3% | −0.6 pts | 40.9% |
| 2023 | 35.0% | −1.3 pts | 36.2% |
| 2022 | -7.8% | +0.5 pts | -8.3% |
| 2021 | 23.3% | +1.6 pts | 21.7% |
| 2020 | 76.9% | +8.1 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.05%
Expense ratio as on 6 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.64%
- Brokerage
- 0.04%
- Transaction charges
- 0.00%
- Statutory levies
- 0.37%
- Exit load
- Exit load of 0.50% if redeemed within 1 month.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -0.47 | 1.49 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.86 | 0.94 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 0.93 | 1.10 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.59 | 1.81 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 15.05 | 15.62 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 5 category peers | |||
Portfolio
DSP Healthcare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity93.3%
- Other6.7%
Market cap split
- Large30.1%
- Mid23.0%
- Small46.9%
- P/E
- 35.24
- P/B
- 4.23
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Ipca Laboratories Ltd. | Healthcare | 8.13% | ₹305 Cr | +8.21% | +9.39% | +7.39% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 7.44% | ₹279 Cr | +8.14% | +9.33% | +7.96% |
| Cipla Ltd. | Healthcare | 7.18% | ₹269 Cr | +8.35% | +7.68% | +8.76% |
| Others | Others | 6.74% | ₹252 Cr | -1.76% | -0.38% | -0.58% |
| Sai Life Sciences Ltd. | Healthcare | 6.52% | ₹244 Cr | +6.88% | +6.02% | +4.77% |
| Gland Pharma Ltd. | Healthcare | 6.15% | ₹231 Cr | +6.54% | +5.40% | +5.96% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 6.07% | ₹228 Cr | +4.81% | +5.00% | +4.69% |
| Globus Medical Inc | Healthcare | 5.15% | ₹193 Cr | +5.72% | +7.58% | +4.45% |
| Alkem Laboratories Ltd. | Healthcare | 4.75% | ₹178 Cr | +2.61% | +0.68% | +0.66% |
| Divi's Laboratories Ltd. | Healthcare | 4.17% | ₹156 Cr | — | — | — |
| Cohance Lifesciences Ltd. | Healthcare | 3.79% | ₹142 Cr | +4.13% | +3.10% | +7.90% |
| Alembic Pharmaceuticals Ltd. | Healthcare | 3.18% | ₹119 Cr | +3.38% | +3.28% | +4.19% |
| Kovai Medical Center & Hospital Ltd. | Healthcare | 2.83% | ₹106 Cr | +2.87% | +2.87% | +3.29% |
| Pfizer Ltd. | Healthcare | 2.72% | ₹102 Cr | +2.53% | +3.28% | +3.29% |
| Concord Biotech Ltd. | Healthcare | 2.70% | ₹101 Cr | +1.81% | +1.75% | +2.63% |
| Procter & Gamble Health Ltd. | Healthcare | 2.36% | ₹88.61 Cr | +2.87% | +2.64% | +3.27% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 2.36% | ₹88.52 Cr | +3.60% | +2.79% | +3.04% |
| Indoco Remedies Ltd. | Healthcare | 2.26% | ₹84.93 Cr | +2.21% | +1.83% | +3.07% |
| Intuitive Surgical Inc. (USA) | Healthcare | 1.95% | ₹73.25 Cr | +2.01% | +2.83% | +2.42% |
| Thyrocare Technologies Ltd. | Healthcare | 1.91% | ₹71.64 Cr | — | — | +0.69% |
| Manipal Health Enterprises Ltd. | Healthcare | 1.85% | ₹69.42 Cr | — | — | — |
| Unichem Laboratories Ltd. | Healthcare | 1.64% | ₹61.57 Cr | +1.46% | +0.86% | +1.28% |
| Syngene International Ltd. | Healthcare | 1.35% | ₹50.60 Cr | +1.38% | — | — |
| Nephrocare Health Services Ltd. | Healthcare | 1.12% | ₹41.89 Cr | +1.22% | +1.11% | — |
| Global X Genomics & Biotechnology ETF | Unclassified | 1.10% | ₹41.44 Cr | +0.94% | +0.88% | +0.69% |
| ICICI Lombard General Insurance Company Ltd. | Insurance | 1.02% | ₹38.38 Cr | +1.20% | +1.43% | +1.48% |
| Aarti Drugs Ltd. | Healthcare | 0.98% | ₹36.72 Cr | +0.92% | +0.94% | +1.35% |
| Abbott Laboratories | Healthcare | 0.80% | ₹29.98 Cr | +0.77% | +1.06% | +1.22% |
| Eris Lifesciences Ltd. | Healthcare | 0.72% | ₹26.92 Cr | — | — | — |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 0.35% | ₹13.10 Cr | +0.38% | +0.42% | +0.47% |
| Grail Inc | Healthcare | 0.31% | ₹11.75 Cr | +0.16% | +0.15% | +0.15% |
| Abbott India Ltd. | Healthcare | 0.26% | ₹9.92 Cr | — | — | — |
| Laxmi Dental Ltd. | Healthcare | 0.14% | ₹5.37 Cr | +0.18% | +0.15% | +0.30% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Manipal Health Enterprises Ltd. | 3.70% | 1.85% | -1.85% |
| Sai Life Sciences Ltd. | 7.45% | 6.52% | -0.93% |
| Others | -0.89% | -0.07% | +0.82% |
| Alkem Laboratories Ltd. | 4.08% | 4.75% | +0.67% |
| Ipca Laboratories Ltd. | 8.74% | 8.13% | -0.61% |
| Sun Pharmaceutical Industries Ltd. | 7.95% | 7.44% | -0.51% |
| Pfizer Ltd. | 3.22% | 2.72% | -0.50% |
| Apollo Hospitals Enterprise Ltd. | 6.47% | 6.07% | -0.40% |
| Globus Medical Inc | 5.44% | 5.15% | -0.29% |
| Abbott India Ltd. | 0.00% | 0.26% | +0.26% |
| Thyrocare Technologies Ltd. | 2.11% | 1.91% | -0.20% |
| Indoco Remedies Ltd. | 2.06% | 2.26% | +0.20% |
| Intuitive Surgical Inc. (USA) | 1.76% | 1.95% | +0.19% |
| Cipla Ltd. | 7.35% | 7.18% | -0.17% |
| Gland Pharma Ltd. | 5.98% | 6.15% | +0.17% |
| Grail Inc | 0.17% | 0.31% | +0.14% |
| Global X Genomics & Biotechnology ETF | 0.98% | 1.10% | +0.12% |
| Vijaya Diagnostic Centre Ltd. | 2.44% | 2.36% | -0.08% |
| Aarti Drugs Ltd. | 0.91% | 0.98% | +0.07% |
| Abbott Laboratories | 0.87% | 0.80% | -0.07% |
| Concord Biotech Ltd. | 2.77% | 2.70% | -0.07% |
| Jupiter Life Line Hospitals Ltd. | 0.40% | 0.35% | -0.05% |
| Alembic Pharmaceuticals Ltd. | 3.14% | 3.18% | +0.04% |
| Eris Lifesciences Ltd. | 0.76% | 0.72% | -0.04% |
| Procter & Gamble Health Ltd. | 2.40% | 2.36% | -0.04% |
| Syngene International Ltd. | 1.31% | 1.35% | +0.04% |
| Kovai Medical Center & Hospital Ltd. | 2.80% | 2.83% | +0.03% |
| ICICI Lombard General Insurance Company Ltd. | 0.99% | 1.02% | +0.03% |
| Cohance Lifesciences Ltd. | 3.81% | 3.79% | -0.02% |
| Divi's Laboratories Ltd. | 4.15% | 4.17% | +0.02% |
| Nephrocare Health Services Ltd. | 1.13% | 1.12% | -0.01% |
| Laxmi Dental Ltd. | 0.14% | 0.14% | 0.00% |
| Unichem Laboratories Ltd. | 1.64% | 1.64% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,934 Cr | 1.89% | 36.5% | 20.8% | 21.6% |
 SBI Healthcare Opportunities Fund | ₹6,067 Cr | 1.98% | 35.0% | 19.9% | 22.6% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — |
 Mirae Asset Healthcare Fund | ₹3,494 Cr | 2.01% | 37.3% | 20.2% | 21.1% |
 UTI Healthcare Fund | ₹1,430 Cr | 2.21% | 30.6% | 18.4% | 21.1% |
 ICICI Prudential Nifty Pharma Index Fund | ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Fund managers
- Chirag DagliMr. Dagli has done B. COM and Chartered Accountant.Prior to joining DSP Mutual Fund, he has worked with HDFC AMC, Aviva India Life Insurance Company Ltd., ICICI Securities Ltd., Pioneer Invest Corp, Deutsche Equities, Citigroup Global Markets.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months17.35% absolute | ₹60,000 | ₹70,410 | 17.35% | |
| 1 year16.88% annualised | ₹1,20,000 | ₹1,31,558 | 9.63% | |
| 3 years20.21% annualised | ₹3,60,000 | ₹4,97,744 | 38.26% | |
| 5 years15.58% annualised | ₹6,00,000 | ₹9,11,602 | 51.93% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.